. Monitoring the absorbance at 499 nm of GSH samples with respect to time. A maximum point for each curve is observed, and specifically the difference between that maximum and the initial values of absorbance were represented as detection values in Figure S2 had changed and increases in absorbance were observed for all tested aliquots derived from reduction of GSSG to GSH. To develop the GSSG + reductant line in Figure 1d (black), we registered the difference between the blank probe (0.0 µM GSSG, black line in this Figure S3 ) and the maximum of the curve for each remaining concentration, as described in Figure S1 for GSH. Figure S4 . Evolution of absorbance with time for cysteine at 499 nm. To develop the cysteine line (green) in Figure 1d , we registered the difference between the blank probe (0.0 µM Cys, black line) and the maximum of the curve for each remaining concentration. Figure S5 . Evolution of absorbance with time for homocysteine at 499 nm. In a similar way to previous analytes, there is a registration of the difference between the blank probe (0.0 µM Hcy) and the maximum value in the curve for each concentration. 1 H-NMR spectrum for 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) in DMSO, 400 MHz, 25 ºC.
S4
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Figure S11. Graphical representation of the sequential determination of reduced and oxidized glutathione GSH and GSSG, promoted by reductive action and working at different wavelengths.
S12
Figure S12. UV-visible spectrum for reductant NADH. Optical interferences were not observed in the area of interest. S13 Figure S13 . Determination of GSH in sera human by means of standard addition procedure. S14 Table S1 . CMYK codes of color for every concentration considered in the preparation of the calibration curve. Ten points for each concentration and tip were randomly selected in the smartphone app to calculate averages and error bars visualized in graph in Fig. 3 . Only magenta index was considered to compose the graph. 
